Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David L Goode

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
Genome Research|January 14, 2010
Evolutionary constraint facilitates interpretation of genetic variation in resequenced human genomesDavid L Goode, Gregory M Cooper, Jeremy Schmutz, et al.
The Journal of Pathology|February 23, 2021
Androgen receptor enhancer amplification in matched patient-derived xenografts of primary and castrate-resistant prostate cancerLaura H Porter, Andrew Bakshi, David Pook, et al.
Plos One|July 30, 2013
High frequency of germline TP53 mutations in a prospective adult-onset sarcoma cohortGillian Mitchell, Mandy L Ballinger, Stephen Wong, et al.
Cancer Cell|July 21, 2015
The H3K4-Methyl Epigenome Regulates Leukemia Stem Cell Oncogenic PotentialStephen H K Wong, David L Goode, Masayuki Iwasaki, et al.
Plos One|March 30, 2011
Salmonella phage ST64B encodes a member of the SseK/NleB effector familyNat F Brown, Brian K Coombes, Jenna L Bishop, et al.
Molecular Oncology|July 24, 2025
Single-cell transcriptomics redefines focal neuroendocrine differentiation as a distinct prostate cancer pathologyRosalia Quezada Urban, Shivakumar Keerthikumar, Ashlee Clark, et al.
Genome Medicine|November 17, 2016
Copy number analysis by low coverage whole genome sequencing using ultra low-input DNA from formalin-fixed paraffin embedded tumor tissueTanjina Kader, David L Goode, Stephen Q Wong, et al.
The Journal of Pathology|April 5, 2024
Co-targeting BET, CBP, and p300 inhibits neuroendocrine signalling in androgen receptor-null prostate cancerNicholas Choo, Shivakumar Keerthikumar, Susanne Ramm, et al.
Cancers|April 3, 2021
Mast Cell-Derived SAMD14 Is a Novel Regulator of the Human Prostate Tumor MicroenvironmentLinda K H Teng, Brooke A Pereira, Shivakumar Keerthikumar, et al.
Molecular Cancer Therapeutics|August 20, 2021
CX-5461 Sensitizes DNA Damage Repair-proficient Castrate-resistant Prostate Cancer to PARP InhibitionMitchell G Lawrence, Laura H Porter, Nicholas Choo, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Genome Research|January 14, 2010
Evolutionary constraint facilitates interpretation of genetic variation in resequenced human genomesDavid L Goode, Gregory M Cooper, Jeremy Schmutz, et al.
The Journal of Pathology|February 23, 2021
Androgen receptor enhancer amplification in matched patient-derived xenografts of primary and castrate-resistant prostate cancerLaura H Porter, Andrew Bakshi, David Pook, et al.
Plos One|July 30, 2013
High frequency of germline TP53 mutations in a prospective adult-onset sarcoma cohortGillian Mitchell, Mandy L Ballinger, Stephen Wong, et al.
Cancer Cell|July 21, 2015
The H3K4-Methyl Epigenome Regulates Leukemia Stem Cell Oncogenic PotentialStephen H K Wong, David L Goode, Masayuki Iwasaki, et al.
Plos One|March 30, 2011
Salmonella phage ST64B encodes a member of the SseK/NleB effector familyNat F Brown, Brian K Coombes, Jenna L Bishop, et al.
Molecular Oncology|July 24, 2025
Single-cell transcriptomics redefines focal neuroendocrine differentiation as a distinct prostate cancer pathologyRosalia Quezada Urban, Shivakumar Keerthikumar, Ashlee Clark, et al.
Genome Medicine|November 17, 2016
Copy number analysis by low coverage whole genome sequencing using ultra low-input DNA from formalin-fixed paraffin embedded tumor tissueTanjina Kader, David L Goode, Stephen Q Wong, et al.
The Journal of Pathology|April 5, 2024
Co-targeting BET, CBP, and p300 inhibits neuroendocrine signalling in androgen receptor-null prostate cancerNicholas Choo, Shivakumar Keerthikumar, Susanne Ramm, et al.
Cancers|April 3, 2021
Mast Cell-Derived SAMD14 Is a Novel Regulator of the Human Prostate Tumor MicroenvironmentLinda K H Teng, Brooke A Pereira, Shivakumar Keerthikumar, et al.
Molecular Cancer Therapeutics|August 20, 2021
CX-5461 Sensitizes DNA Damage Repair-proficient Castrate-resistant Prostate Cancer to PARP InhibitionMitchell G Lawrence, Laura H Porter, Nicholas Choo, et al.
Pageof 4